Consider Meds for Persistent Stage 1 HTN at 6 Months, AHA Says
Consideration should be given to addition of meds for adults not meeting BP goals after 6 months of lifestyle therapy
Hypertension
Diovan Approved for Younger Patients With Hypertension
The approval was based on data from 3 clinical studies that assessed the antihypertensive effect of valsartan in 290 children 1 to less than 6 years of age.
Migraine Linked to Hypertension in Menopausal Women
Slightly stronger association was seen for ever users of menopausal hormone therapy than never users.
Medical and Surgical Management of Aldosteronism
The authors explore the etiology and clinical presentation of primary and secondary aldosteronism as well as medical and surgical treatment options.
Focus on Hypertension for American Heart Month: Resources for Clinicians
A number of clinical resources are available to help clinicians provide care and support for their patients with hypertension and encourage them to adopt healthy lifestyles.
Health Promotion and Appropriate Treatment for Black Women With Hypertension
Compared with White women, Black women are more likely to be diagnosed with hypertension at a younger age, have higher blood pressure readings, and die earlier from complications related to hypertension.
USPSTF Finds Evidence Lacking for Child Hypertension Screening
The USPSTF concludes that current evidence is inadequate for assessing the balance of benefits and harms of screening children and adolescents for hypertension.
Obesity May Affect Quality of Life in Pulmonary Arterial Hypertension
Adult patients with pulmonary arterial hypertension (PAH) who were also obese had worse disease-specific health-related quality of life compared to patients of normal weight.
Trends in Age at CVD Diagnosis in Men and Women Between 2008 and 2017
There is a trend toward a decreasing age for diagnosis of cardiovascular disease and associated risk factors among women.
ACE Inhibitor, ARB Treatments Not Found to Increase Rates of COVID-19 Infection, Mortality
Treatment with ACEI and/or ARBs was not found to increase the rates of COVID-19 infection or associated mortality.
-
Loading...
-
Loading...
Next post in AHA 2020
